News
-
Press
Jul 17, 2023
ThinkCyte and FIMM Establish Research Partnership to Advance Understanding and Treatment of Blood Cancer
-
Press
Apr 17, 2023
Juntendo University, Sysmex, and ThinkCyte collaborate to advance the early detection and treatment of blood cancer
-
Press
Apr 10, 2023
ThinkCyte primed for continued growth as it expands with new Bay Area headquarters
-
Events
Apr 6, 2023
ThinkCyte to Showcase VisionSort at the 2023 American Association for Cancer Research (AACR) Annual Meeting
-
Press
Mar 3, 2023
ThinkCyte reveals VisionSort™, the world’s first dual mode, AI-driven cell characterization and sorting platform.
-
Events
Feb 13, 2023
ThinkCyte to Debut VisionSort at the 2023 Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition
-
Press
Jan 23, 2023
ThinkCyte broadens Advisory Board with the appointments of Dr. Diether Recktenwald, Ph.D. and Dr. Bo Saxberg, M.D. Ph.D.
-
Press
Dec 26, 2022
ThinkCyte and Axcelead DDP collaborate to advance novel phenotypic drug screening methods
-
Press
Dec 13, 2022
PhoreMost and ThinkCyte collaborate to advance AI-based drug discovery
-
Events
Dec 6, 2022
ThinkCyte to Showcase Ghost Cytometry at the 64th ASH Annual Meeting and Exposition
-
Press
Dec 6, 2022
Vision Care Group and ThinkCyte Announce Research Alliance in Advanced Cell Therapy
-
Press
Jul 21, 2022
ThinkCyte announces Premier Early Access Program for its new label-free cell characterization and sorting system
-
Press
Jul 11, 2022
ThinkCyte shares applications of Ghost Cytometry with industrial and academic thought leaders
-
Press
Jun 23, 2022
ThinkCyte Establishes Presence in the Bay Area and Strengthens Senior Management Team With Industry Veteran
-
Press
Dec 21, 2021
ThinkCyte’s novel label-free in-silico ghost cytometry published in eLife
-
Press
May 19, 2021
ThinkCyte Secures $26 Million in Series B Financing
-
Press
May 12, 2021
Sysmex and ThinkCyte Agree on Joint Development and Capital Alliance
-
Press
Aug 24, 2020
ThinkCyte Awarded NEDO PCA Grant to Advance Label-free Cell Sorting Technology for Cell Therapy
-
Press
Jul 9, 2020
ThinkCyte and National Cancer Center Japan Jointly Awarded AMED Grant for Isolation of Circulating Tumor Cells
-
Press
Jul 1, 2020
Hitachi and ThinkCyte Announce Collaboration to Develop an AI-driven Cell Analysis and Sorting System
-
Press
May 29, 2020
ThinkCyte Completes $15 Million Series A Financing
-
Information
Jun 24, 2019
ThinkCyte Selected for J-Startup Program
-
Information
Dec 20, 2018
ThinkCyte Graduated Berkeley SkyDeck Cohort Program
-
Information
Nov 1, 2018
ThinkCyte Selected for the Inaugural Class of Google Launchpad Accelerator Tokyo
-
Press
Jun 15, 2018
ThinkCyte Publishes Paper on “Ghost Cytometry” Method in Science
-
Press
Jun 15, 2018
ThinkCyte Completes Seed Financing